PSCH:NSD-PowerShares S&P SmallCap Health Care Portfolio (USD)

ETF | Health | NASDAQ Global Market

Last Closing

USD 48.93

Change

+1.03 (+2.15)%

Market Cap

USD 0.18B

Volume

7.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the S&P SmallCap 600? Capped Health Care Index. The fund generally will invest at least 90% of its total assets in common stocks of small capitalization U.S. healthcare companies that comprise the underlying index. These companies are principally engaged in the business of providing healthcare-related products, facilities and services, including biotechnology, pharmaceuticals, medical technology and supplies. The fund is non-diversified.

Inception Date: 07/04/2010

Primary Benchmark: S&P Small 600 Cap HealthCare TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.29%

Management Expense Ratio: 0.29 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
IBB iShares Biotechnology ETF 0.47 %

+0.69 (+0.50%)

USD 6.39B
PPH VanEck Pharmaceutical ETF 0.36 %

+0.64 (+0.71%)

USD 0.55B
BBH VanEck Biotech ETF 0.35 %

+1.08 (+0.66%)

USD 0.40B
PTH Invesco DWA Healthcare Momentu.. 0.60 %

-0.63 (-1.37%)

USD 0.13B
GNOM Global X Genomics & Biotechnol.. 0.00 %

-0.13 (-1.25%)

USD 0.07B
FTXH First Trust Nasdaq Pharmaceuti.. 0.60 %

+0.20 (+0.70%)

USD 0.02B
CNCR Loncar Cancer Immunotherapy ET.. 0.79 %

-0.23 (-1.80%)

USD 0.01B

ETFs Containing PSCH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.48% 88% B+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.48% 88% B+ 77% C+
Trailing 12 Months  
Capital Gain 15.18% 100% F 66% D+
Dividend Return 0.24% 33% F 2% F
Total Return 15.42% 100% F 65% D
Trailing 5 Years  
Capital Gain 7.95% 38% F 56% F
Dividend Return 0.23% 29% F 1% F
Total Return 8.18% 38% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 0.71% 63% D 41% F
Dividend Return 0.75% 50% F 36% F
Total Return 0.04% 38% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 30.40% 13% F 61% D-
Risk Adjusted Return 2.46% 50% F 36% F
Market Capitalization 0.18B 63% D 47% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.